Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats

[1]  G. Vercellotti,et al.  Factor Primes Neutrophil Responses to Agonists: Role in Promoting Neutrophil-Mediated Endothelial Damage , 2016 .

[2]  F. A. Moore,et al.  Sequential systemic platelet‐activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure , 1996, The British journal of surgery.

[3]  C. Thiemermann,et al.  Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat , 1996, British journal of pharmacology.

[4]  M. O'riordain,et al.  Dosage and Timing of Anti-TNF-α Antibody Treatment Determine Its Effect on Resistance to Sepsis after Injury , 1996 .

[5]  D. Hoyt,et al.  Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment--role of circulating TNF-alpha and IL-beta? , 1996, Shock.

[6]  K. Ikejima,et al.  A diet containing glycine improves survival in endotoxin shock in the rat. , 1996, The American journal of physiology.

[7]  E. Moore,et al.  Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. , 1996, New horizons.

[8]  P. Renesto,et al.  Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils , 1996, British journal of pharmacology.

[9]  L. Golub,et al.  Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy. , 1996, Research communications in molecular pathology and pharmacology.

[10]  L. Toledo-Pereyra,et al.  Time dependence of Na-nitroprusside administration in the prevention of neutrophil infiltration in the rat ischemic kidney. , 1996, Transplantation.

[11]  K. Takatsuki,et al.  Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. , 1996, Blood.

[12]  M. Büchler,et al.  Serum phospholipase A2 in patients with multiple organ failure. , 1996, The Journal of surgical research.

[13]  A. Kingsnorth.  Platelet-activating factor. , 1996, Scandinavian journal of gastroenterology. Supplement.

[14]  C. Waydhas,et al.  Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. , 1994, The Journal of trauma.

[15]  Lee Ch,et al.  Distribution and role of lipopolysaccharide in the pathogenesis of acute renal proximal tubule injury. , 1995 .

[16]  H. Kimura,et al.  Synthesis and antipancreatitis activities of novel N-(2-sulfonylamino-5-trifluoromethyl-3-pyridyl)carboxamide derivatives as phospholipase A2 inhibitors. , 1995, Chemical & pharmaceutical bulletin.

[17]  S. Gando,et al.  Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase. , 1995, The Journal of trauma.

[18]  M. Perretti,et al.  Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. , 1995, Biochemical pharmacology.

[19]  T. Bentley,et al.  DISTRIBUTION AND ROLE OF LIPOPOLYSACCHARIDE IN THE PATHOGENESIS OF ACUTE RENAL PROXIMAL TUBULE INJURY , 1995, Shock.

[20]  F. Guarner,et al.  Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. , 1995, Gastroenterology.

[21]  R. McIntyre,et al.  Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. , 1995, The American journal of physiology.

[22]  T. Hayakawa,et al.  Effect of a selective inhibitor of cytosolic phospholipase A2 (cPLA2) on experimental acute pancreatitis , 1995 .

[23]  P. Ward,et al.  Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. , 1995, Journal of immunology.

[24]  R. Goris,et al.  Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. , 1995, Critical care medicine.

[25]  E. Benfenati,et al.  Involvement of a serine protease in the synthesis of platelet‐activating factor by endothelial cells stimulated by tumor necrosis factor‐α or interleukin‐1α , 1994 .

[26]  P. Bernstein,et al.  Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketones. , 1994, Journal of medicinal chemistry.

[27]  K. Ohlsson,et al.  Levels of leukocyte proteases in plasma and peritoneal exudate in severe, acute pancreatitis. , 1994, Scandinavian journal of gastroenterology.

[28]  E. Moore,et al.  Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. , 1994, The Journal of surgical research.

[29]  H. Egami,et al.  The role of tumor necrosis factor-α in the aggravation of cerulein-induced pancreatitis in rats , 1993 .

[30]  R. Pauwels,et al.  The effect of zardaverine, an inhibitor of phosphodiesterase isoenzymes III and IV, on endotoxin‐induced airway changes in rats , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  K. Katayama,et al.  Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models. , 1991, Arzneimittel-Forschung.

[32]  M. Suzuki,et al.  ONO-5046, a novel inhibitor of human neutrophil elastase. , 1991, Biochemical and biophysical research communications.

[33]  T. Mase,et al.  Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor. , 1990, Archives internationales de pharmacodynamie et de therapie.

[34]  D. Remick,et al.  Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. , 1989, The Journal of clinical investigation.

[35]  G. Camussi,et al.  Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. , 1988, The Journal of biological chemistry.

[36]  W. Hsueh,et al.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. , 1988, The Journal of clinical investigation.

[37]  G. Vercellotti,et al.  Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. , 1988, Blood.

[38]  A. Mantovani,et al.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.

[39]  J. Gamble,et al.  Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.

[40]  R. Graf.  Reactions with N‐Carbonylsulfamoyl Chloride , 1968 .